In brief: New York’s John Quinlan named Van Miller Homecare Champion

WASHINGTON – AAHomecare has announced that John Quinlan is this year’s Van Miller Homecare Champion, recognizing three decades of extraordinary leadership, generosity, spirit of caring and service to the HME community.   
     
Quinn, president and CEO of Quinlan's Pharmacy and Medical Equipment, also has held industry leadership roles, including Chair of the AAHomecare State Leaders Council, service on AAHomecare’s Executive Committee, Board of Directors, and Payer Relations Council, along with his tenure as president of NEMEP.  

"John’s compassion and passion for supporting patients, along with his persistent advocacy, have made him a trusted and respected voice in HME,” said Tom Ryan, president and CEO of AAHomecare. "A tireless champion for protecting access to quality care, he embodies exactly what the Homecare Champion Award is meant to celebrate."  

AAHomecare will recognize John's Quinlan with the Van Miller Homecare Champion Award during the AAHomecare Update at Medtrade on March 3 at 2:15.  

Read about some of Quinlan’s advocacy work: Stakeholders get parity bill passed in NY & Medicaid unbundles CPAP payments in NY  

Med Supplies Council launches impact survey  

WASHINGTON – AAHomecare’s Medical Supplies Council has launched a nationwide Market Impact Survey to assess the ongoing effects of reimbursement levels, supply chain volatility, product and operational costs, and staffing pressures across a variety of disposable supplies as well as CGMs and insulin infusion pumps.    

Product categories included in survey  

• Ostomy supplies  

• Urological supplies  

• Continuous Glucose Monitors (CGMs)  

• Insulin infusion pumps  

• Incontinence supplies  

• Woundcare supplies  

• Enteral nutrition  

All HME suppliers who provide any of the included products are encouraged to take the survey here.  Insights gathered from the 2026 survey will be critical in advocacy efforts for Competitive Bidding, state Medicaid discussions, and payer education to help quantify the growing gap between reimbursement and the cost of providing care. All information gathered will be confidential and will only be reflected in aggregate data.   

“We are very excited about this project,” said Laura Berry of Soundview Medical Supply and chair of the Medical Supplies Council. “As an industry, our medical supply products are facing more challenges than ever. It is critical that we have up-to-date information to share with decision-makers to help protect reimbursement, our companies, and our continued ability to serve our customers.”  

Deadline to take the survey is March 13. Take the survey here. For questions about the survey initiative, contact Stephanie at stephaniel@aahomecare.org.    

Insulet’s Omnipod continues to deliver  

ACTON, Mass. – Insulet Corporation reported revenue of $783.8 million for the fourth quarter of 2025, an increase of 31% over the same period a year prior and ahead of the company’s guidance in the 25% to 28% range.   

Of that, U.S. Omnipod revenue was $567.8 million and international Omnipod revenue was $214 million.  

For the full year, Insulet reported revenue of $2.7 billion, an increase of 30.7%, over the previous year. Of that, U.S. revenue was $1.9 billion and international revenue was $754.3 million.   

“We ended the year with another excellent quarter, demonstrating the power of our business model, the strength of our technology, and the disciplined execution of our team,” said Ashley McEvoy, president and CEO. “Our performance shows that Insulet continues to lead with innovation, scale, and customer trust — and that our competitive position has never been stronger. As we move into 2026, we are confident in our ability to grow the global AID market, expand adoption across type 1 and type 2 diabetes, and deliver on the strategic and financial commitments we have laid out. Insulet has the talent, the technology, and the momentum to lead this category for the long term.”  

Other highlights:  

• Achieved a significant milestone of more than 600,000 estimated active Omnipod users globally, reflecting continued adoption across U.S. and international markets.  

• Received U.S. FDA clearance for significant Omnipod 5 algorithm enhancements, delivering greater customization, tighter glucose management, and the ability for users to remain in automated mode longer—further simplifying the Pod experience.  

• Expanded Omnipod 5 U.S. recycling program, diverting millions of Pods from landfills and creating a more sustainable future.  

• Received approval from the Board of Directors for a $350 million increase in our share repurchase authorization.   

Rich Shadwick joins AAHomecare board 

WASHINGTON – AAHomecare’s Board of Directors has approved the addition of Rich Shadwick, US Sales Leader, Sleep and Respiratory Care with Philips Respironics, to fill a vacated at-large seat. Shadwick brings extensive leadership experience developed over more than 25 years in the home-based care and pharmaceutical sectors, including the last 19 years with Philips.  In his current role, he oversees U.S. regional sales director and territorial managers and has led the development of elite sales practices and fostered a customer-first, performance driven culture. “After 24 years in homecare—starting as a respiratory therapist caring for patients in their homes and long-term facilities, then moving into sales and leadership roles at Philips I’m excited to join the AAHomecare board,” said Shadwick. “I’ve witnessed how powerfully home-based care improves lives, and I’m eager to help the association strengthen advocacy, spark innovation, and empower cost-effective, patient-first care.”   
     
CERT report shows improper payment increase  

WASHINGTON – The Centers for Medicare and Medicaid Services (CMS) recently published the 2025 Comprehensive Error Rate Testing (CERT) Improper Payment Report which shows an increase in improper payments for DMEPOS for the first time since 2015. The 2025 improper payment rate for DMEPOS was reported to be 24.1%, which is a 2.7% increase since the previous year, according to a bulletin from AAHomecare. The 2025 report data is based on claims analyzed from July 1, 2023, to June 30, 2024. AAHomecare reviews the report in detail each year to help educate the supplier community on specific policy groups and supplier types that have higher improper payment rates.  In addition, AAHomecare continues to have discussions with CMS and the DME MACs on audit opportunities based on the report.   

DME MACs to conduct prepayment reviews for new urological suppliers  

Due to the high improper payment rate reported in the 2025 CERT report, the DME MACs for Jurisdictions B and C have announced they will be conducting a widespread pre-payment review of urological supplies submitted by new suppliers.   
Only new suppliers will be pursued. The DME MACs will be sending additional documentation requests (ADR) for impacted claims. The ADR will include requests for the following items before the DME MACs will pay for the claim:   

Treating practitioner's written order.  

• Relevant medical records that support it is medically necessary to perform intermittent catheterization.  
• Any other pertinent documentation.  
• Copy of Advance Beneficiary Notice (ABN) if one was obtained.  

Additionally, for sterile intermittent catheter kits, medical records must document that the beneficiary meets one of the coverage criteria listed in the Urological Supplies Local Coverage Determination specific to sterile intermittent catheter kits.  

You can find the announcement on CGS’s website.   

Deadline extended for bid sign-on letter  

WASHINGTON – The deadline for a Congressional sign-on letter asking CMS Administrator Mehmet Oz to delay the competitive bidding program (CBP) for ostomy and urological supplies has been extended to Marc 6, according to AAHomecare. The letter is being spearheaded by Rep. Chris Smith, R-N.J. DME companies that furnish these supplies are encouraged to ask their representative to join the sign-on letter to allow for a thorough review of serious concerns arising from their potential inclusion in the CB program.   

View the letter here.  
   
ProSomnus receives $38M investment to grow in alternative sleep market  

SAN FRANCISCO – ProSomnus has raised $38 million through a strategic investment from Catalio Capital Management to accelerate the expansion of its sleep health platform, according to a report from MassDevice.com.   

ProSomnus develops non-CPAP obstructive sleep apnea (OSA) therapy offerings. With the investment, it plans to advance the development of next-generation remote patient monitoring and proprietary sleep diagnostic devices. It hopes to meet the rising demand for patient-preferred OSA therapies, with alternatives like its intraoral medical devices, which precisely track the treatment plan and anatomy of each patient.   

The FDA-cleared, non-invasive mouthguard-like devices have the backing of a “growing body of clinical investigations,” ProSomnus says.   

“Catalio’s investment affirms our mission to address the global public health burden of obstructive sleep apnea with precision, datadriven medical solutions that create meaningful value loops for patients, clinicians, and payers,” Len Liptak, CEO of ProSomnus, said. “Demand for effective, economical, and patientpreferred therapies continues to build. This partnership enables ProSomnus to expand access to care while advancing and scientifically validating our next generation sensorenabled medical devices. We appreciate Catalio’s partnership and look forward to accelerating the worldwide adoption of smart sleep medicine.”  

ProSomnus in September 2023 completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital.   

Less than a year later, in May 2024, the company filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware, listing more than $26.3 million in assets and $52.89 million in debts.   

“The voluntary restructuring announced today will enable us to move ahead as a stronger company,” said Liptak at that time. “Reestablishing a healthy financial foundation for our company, with the support of our lenders, we expect to leave the process with more cash, less debt, less expense, and more time to focus on devices, customers and patients.”  

Federal gov’t indicts two in $10M fraud scheme  

CHICAGO – Two foreign nationals participated in a $10 million scheme to fraudulently bill Medicare and private insurers for nonexistent health care services, according to an indictment returned in federal court in Chicago.  

In 2023 and 2024, Burhan Mirza and Kashif Iqbal, along with several co-schemers, used nominee-owned laboratories and durable medical equipment (DME) providers to submit fraudulent claims to Medicare and private health care benefit programs for items and services that were not provided, the indictment states. Mirza, 31, is a Pakistani native who resided in Pakistan and obtained the identifying information of individuals, providers and insurers without their knowledge and used the information to support the bogus claims submitted on behalf of the nominee-owned companies, the indictment states. Iqbal, 48, is a Pakistani native who resided in Lavon, Texas, and was allegedly associated with a number of DME providers that submitted fraudulent claims to insurers. Iqbal also laundered fraud proceeds obtained by the co-schemers and coordinated the transfer of money obtained through the scheme to Pakistan, the indictment states.  

“Rooting out fraud is a priority for this Justice Department, and these defendants allegedly billed millions of dollars from Medicare and laundered the proceeds to Pakistan,” said Deputy Attorney General Todd Blanche. “These alleged criminals stole from a program designed to provide health care benefits to American seniors and the disabled, not line the pockets of foreign fraudsters. We will not tolerate these schemes that divert taxpayer dollars to criminals.”   

The indictment charges Mirza with 12 counts of health care fraud and five counts of money laundering. Iqbal is charged with 12 counts of health care fraud, six counts of money laundering, and one count of making a false statement to U.S. law enforcement. Arraignments in federal court in Chicago have not yet been scheduled.  

Geriatric Medical, DDP Medical make executive promotions  

WOBURN, Mass. — GMSS Holdings, the parent company of Geriatric Medical and DDP Medical Supply, announced executive leadership promotions aimed at supporting continued growth and operational alignment across its long-term care and durable medical equipment (DME) distribution platform.   

JJ Pistoor has been promoted to chief revenue officer (CRO). Since joining the company in 2018, Pistoor has led initiatives focused on market expansion, customer engagement, and revenue performance. In his new role, he will oversee sales, business development, marketing, and customer success functions across both Geriatric Medical and DDP Medical Supply. He is also active in industry advocacy through leadership roles with national homecare and DME trade associations.  

Andrew Marenco has been appointed chief financial officer & chief operating officer (CFO & COO). Marenco joined the company as CFO in 2021 and has led efforts to enhance financial reporting, strengthen capital planning, and support operational scalability. In his expanded role, he will continue to oversee finance while assuming responsibility for operations, including supply chain, logistics, and organizational execution across both businesses.  

“These leadership appointments reflect the continued evolution of our organization as we scale to meet the needs of providers across long-term care and DME markets,” said Jeffrey Siegal, CEO of GMSS Holdings. “JJ’s leadership across revenue functions and Andrew’s expanded operational oversight position us to further align strategy and execution while maintaining the service model our customers depend on.”  

OPGA opens application process for prosthetics grants  

WATERLOO, Iowa — OPGA has announced that the application period is officially open for two grants available to U.S.–based orthotic and prosthetic (O&P) professionals: the Russell Walker CP, LP Emerging Leader Grant and the Todd Eagen Advocacy in Action Memorial Grant. Sponsored by Össur and presented by OPGA, both grants provide funding for meaningful, non-clinical experiences that strengthen leadership skills, deepen advocacy engagement, and enhance connection with the patients and communities served by O&P professionals. The Russell Walker CP, LP Emerging Leader Grant pays tribute to Russell “Rusty” Walker, an O&P practitioner known for his passion for mentoring the next generation of O&P leaders. The Todd Eagen Advocacy in Action Memorial Grant honors the legacy of Todd Eagen, former president of OPGA, who worked tirelessly to elevate the O&P profession. “At OPGA, our mission is to support and empower the individuals who drive the O&P profession forward,” said Jeff Kessler, director of OPGA. “These grants honor two remarkable leaders while helping today’s residents and certified practitioners strengthen their leadership capacity, expand their advocacy experience, and ultimately improve the lives of the patients they serve. We encourage all eligible professionals to apply and take advantage of this unique opportunity to grow both personally and professionally.” In 2025, Avery-Claire Littleton received the Russell Walker CP, LP Emerging Leader Grant, and Nicole Bakovich received the Todd Eagen Advocacy in Action Memorial Grant. Grant applications are due March 6, 2026. A selection committee consisting of O&P professionals will review all applications, and the recipients will be notified and announced at the end of March 2026. For more information about the grants and to apply, click here.